$ZNGA: Why Zynga Is Back in Favor on Wall Street

Date: Thursday, May 2nd, 2019

Stock(s) mentioned:

Source: 24/7 Wall St. (https://247wallst.com)

Summary: In the case of Zynga Inc. (NASDAQ: ZNGA), it has been under $10 per share since 2012, after a $9.50 IPO price back in 2011. And the reality is that Zynga has …

Full article address: https://247wallst.com/media/2019/05/02/why-zynga-is-back-in-favor-on-wall-street/

Related News:

$UBER $LYFT $APRN $ZNGA $GRPN: WeWork’s CEO Dumped a Lot of Stock Ahead of its IPO. Red Flag?

$ZNGA $TTWO $ATVI: Zynga’s Shares Will Start Rising Again, Analyst Says

$ZNGA: How Does Zynga’s Mobile Platform Gaming Revenue Compare To …

$ZNGA $GLUU: Electronic Arts: Company Needs Mobile Gaming Help

$ZNGA: Zynga’s Original Hit Game FarmVille Marks 10-Year Anniversary …

$FB $ZNGA $TGT: Facebook Cryptocurrency Push Is About Bringing Users to Its Platform

$SNAP $ZNGA: Will Zynga’s “Little Royale” Popularize Snapchat’s Gaming Platform?

$GWR $ZNGA: Here’s What Hedge Funds Think About Genesee & Wyoming Inc …

$ZNGA $ACB: 7 High-Quality Cheap Stocks to Buy With $10

$ZNGA: Zynga Inc. Announces Pricing of Offering of $600 Million of …

$ZNGA: Why Zynga Stock Gained 11.1% in May

Latest News:

$UTX $RTN: United Technologies Posts Earnings Beat and Raises Guidance

$WAIR $LMT $HEI $TDY: 4 Defense Stocks to Gain From the Bipartisan Budget Deal

$SYK $DVA $XRAY $ABC: DaVita (DVA) Announces Preliminary Q2 Results, View Upbeat

$CPA $CAR $SBAC $CWEN: SBA Communications (SBAC) to Report Q2 Earnings: What’s Up?

$NINOY $BABA $LOGI $KEYS: Logitech (LOGI) Q1 Earnings & Revenues Top Estimates, Up Y/Y

$OII $HAL: Halliburton (HAL) Surges: Stock Moves 9.2% Higher

$GSK: The Wall Street Journal: 23andMe and GSK are mining customers’ DNA data in a hunt for new drugs

$CLU19 $RBQ19 $HOU19 $NGQ19: Futures Movers: Oil edges lower as traders play down Iran tensions

$BIIB: Biogen profit rises 72%

$WHR: Whirlpool earnings beat estimates as higher prices offset tariff impact

$ACAD: Acadia’s schizophrenia treatment misses late-stage main goal; shares tank 16%